share_log

HC Wainwright & Co. Maintains Buy on Sangamo Therapeutics, Maintains $3 Price Target

HC Wainwright & Co. Maintains Buy on Sangamo Therapeutics, Maintains $3 Price Target

HC Wainwright & Co.维持对Sangamo Therapeutics的买入,维持3美元的目标股价
Moomoo 24/7 ·  03/13 12:48

HC Wainwright & Co. analyst Patrick Trucchio maintains Sangamo Therapeutics (NASDAQ:SGMO) with a Buy and maintains $3 price target.

HC Wainwright & Co. 分析师帕特里克·特鲁基奥维持Sangamo Therapeutics(纳斯达克股票代码:SGMO)的买入并维持3美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发